Qiagen NV (WBO:QGE2)
€ 40.8 -0.54 (-1.31%) Market Cap: 9.01 Bil Enterprise Value: 9.48 Bil PE Ratio: 137.61 PB Ratio: 2.86 GF Score: 87/100

Qiagen NV at Citi Healthcare & Medtech Conference Transcript

Mar 01, 2023 / 03:15PM GMT
Release Date Price: €44.02 (-2.11%)
Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

All right. Well, thank you, everybody, for joining us. I'm Patrick Donnelly, the tools and diagnostics analyst here. We have Thierry Bernard, the CEO of QIAGEN. He is virtual today, scheduled to be here, but wasn't able to make it. So we do -- we have him on the Zoom here. So Thierry, thanks for joining us. Thanks for being here in a virtual setting at least.

Thierry Bernard
QIAGEN N.V. - CEO, MD & Member of Management Board

Thanks for the invitation. And I apologize for not being able to be with you in New York, sincere apologies, yes.

Questions & Answers

Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

Not a problem. So maybe we can start just fresh off 4Q. I know a lot of the companies are just kind of rehashing what happened there to start things off. You guys reported a pretty clean beat, kind of gave the initial '23 guidance. But maybe we can start just talking through some of the moving

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot